Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
Current Opinion in Molecular Therapeutics


 

Current Opinion in Molecular Therapeutics gives you a broader, better organised and more clearly defined coverage of all the major areas of research in the exciting field of molecular medicine.

Current Opinion in Molecular Therapeutics is recognised as the review journal in this exciting field. Covering topics suggested by our renowned international Editorial Board, as well as highlights and expert opinions on the latest disclosures in the literature, this bimonthly journal will ensure that you are aware of all the significant developments in molecular medicine.

A wide range of topics are covered to give you the broadest possible coverage while still retaining the in-depth quality of the peer-reviewed content.



THE SECTIONS ARE AS FOLLOWS:

  • Clinical applications of gene therapy
  • Genomics, proteomics and pharmacogenetics - Therapeutic approaches
  • Molecular, viral and cell-based vaccines for disease prevention and therapy
  • Oligonucleotide, antibody and peptide therapeutics - From design to the clinic
  • Genomics, proteomics and pharmacogenetics - Experimental approaches
  • Gene transfer and cell-based therapies

We are sure that once you have read Current Opinion in Molecular Therapeutics you will agree that it will form an indispensable part of your knowledge library.




 


 

Additional Information

Subscribe

Contact
Barbara Chan, Managing Editor
barbara.chan@thomson.com

 
Disclaimer | Terms of Use
Privacy Policy | Copyright